DBT Human Pre-designed siRNA Set A contains three designed siRNAs for DBT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DBX1 Human Pre-designed siRNA Set A contains three designed siRNAs for DBX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DBX2 Human Pre-designed siRNA Set A contains three designed siRNAs for DBX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DC-SX029 is a potent SNX10 protein-protein interaction (PPI) inhibitor with an estimated KD constant of ~0.935 μM by surface plasmon resonance (SPR). DC-SX029 blocks the SNX10-PIKfyve interaction, thereby decreased the TBK1/c-Rel signaling activation. DC-SX029 does not affect the protein level of SNX10. DC-SX029 has the potential for inflammatory bowel disease (IBD) research[1].

DC-TEADin04 has weak inhibitory activity against TEAD4 palmitoylation[1].

DC4 Crosslinker is a stable crosslinking reagent with improved activity and solubility. DC4 Crosslinker is labile cleavable with collision-induced dissociation (CID), that will be fragmented into four rearrange products containing mobilized protons[1].

DCAF1 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF11 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF12 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF12 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF13 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF13 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF15 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF15 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF16 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF16 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF17 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF4 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF4L2 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF4L2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF5 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF7 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCAF8 Human Pre-designed siRNA Set A contains three designed siRNAs for DCAF8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCBLD1 Human Pre-designed siRNA Set A contains three designed siRNAs for DCBLD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCBLD2 Human Pre-designed siRNA Set A contains three designed siRNAs for DCBLD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCC Human Pre-designed siRNA Set A contains three designed siRNAs for DCC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can promote autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects[1].

DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can promote autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects[1].

DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can promote autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects[1].

DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can promote autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects[1].

DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can promote autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects[1].

DCD Human Pre-designed siRNA Set A contains three designed siRNAs for DCD gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCDC1 Human Pre-designed siRNA Set A contains three designed siRNAs for DCDC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCDC2 Human Pre-designed siRNA Set A contains three designed siRNAs for DCDC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCHS1 Human Pre-designed siRNA Set A contains three designed siRNAs for DCHS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCHS2 Human Pre-designed siRNA Set A contains three designed siRNAs for DCHS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCK Human Pre-designed siRNA Set A contains three designed siRNAs for DCK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCLK1 Human Pre-designed siRNA Set A contains three designed siRNAs for DCLK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCLK1-IN-5 (Compound a24) is a DCLK1 inhibitor (IC50: 179.7 nM). DCLK1-IN-5 inhibits lipopolysaccharide (HY-D1056)-induced inflammation via inhibiting DCLK1-mediated IKKβ phosphorylation. DCLK1-IN-5 protects mice against inflammation-induced lung injury and sepsis[1].

DCLK2 Human Pre-designed siRNA Set A contains three designed siRNAs for DCLK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCLK3 Human Pre-designed siRNA Set A contains three designed siRNAs for DCLK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCLRE1B Human Pre-designed siRNA Set A contains three designed siRNAs for DCLRE1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCLRE1C Human Pre-designed siRNA Set A contains three designed siRNAs for DCLRE1C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCN Human Pre-designed siRNA Set A contains three designed siRNAs for DCN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCP-Rho1 is a rhodamine-labeled probe. DCP-Rho1 can be used for the detection of sulfenic acid-containing proteins. DCP-Rho1 shows λex of 560 nM, λem, 581 nm[1].

DCP1A Human Pre-designed siRNA Set A contains three designed siRNAs for DCP1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCP1B Human Pre-designed siRNA Set A contains three designed siRNAs for DCP1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCP2 Human Pre-designed siRNA Set A contains three designed siRNAs for DCP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCPS Human Pre-designed siRNA Set A contains three designed siRNAs for DCPS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCST1 Human Pre-designed siRNA Set A contains three designed siRNAs for DCST1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCST2 Human Pre-designed siRNA Set A contains three designed siRNAs for DCST2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

DCSTAMP Human Pre-designed siRNA Set A contains three designed siRNAs for DCSTAMP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.